
Hyderabad-based company NiedlFree has announced a potential game-changer for diabetics with the development of Ozulin, an oral insulin spray. This needle-free alternative could offer a convenient and less painful method for individuals, particularly those with type 1 diabetes, to regulate their blood sugar levels. Ozulin, if approved, allows doses to be sprayed directly into the mouth, providing a more accessible option for administering insulin, especially when away from home. The company has applied to the Central Drugs Standard Control Organisation (CDSCO) for approval to conduct safety and toxicology studies, with human trials expected to follow.
Like
Save
Share